NCT02968368View on ClinicalTrials.gov

Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

167

Participants

Timeline

Start Date

December 1, 2016

Primary Completion Date

January 18, 2018

Study Completion Date

October 10, 2018

Conditions
Renal Insufficiency, ChronicIron-Deficiency Anemia
Interventions
DRUG

Ferric maltol

OTHER

Placebo

Trial Locations (27)

Unknown

Peoria

Phoenix

Prescott

Tucson

La Mesa

Long Beach

Roseville

Sacramento

Denver

Coral Springs

Edgewater

Lauderdale Lakes

Miami

Macon

Shreveport

Pontiac

Roseville

Las Vegas

Asheville

Charlotte

Wilmington

Bethlehem

Knoxville

Nashville

El Paso

San Antonio

Hampton

Sponsors
All Listed Sponsors
lead

Shield Therapeutics

INDUSTRY

NCT02968368 - Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease | Biotech Hunter | Biotech Hunter